PMDA drug package insert
アコアラン静注用600
PMDA Prescription drug · 協和キリン株式会社 · package insert Jun 18, 2025
Key facts
| Brand names | アコアラン静注用600, アコアラン静注用1800 |
|---|---|
| Nonproprietary names | アンチトロンビン ガンマ（遺伝子組換え） |
| Companies | 製造販売元／協和キリン株式会社, 販売元／一般社団法人 日本血液製剤機構 |
| Product type | Prescription drug |
| Therapeutic category | 血液凝固阻止剤 |
| Therapeutic category codes | 876349 |
| YJ codes | 6343444D1021, 6343444D2028 |
| Approval numbers | 22700AMX00695, 22900AMX00951 |
| Package insert edition | 第6版 |
| Package insert date | Jun 18, 2025 |
| PMDA document key | 230124_6343444D1021_1 |
| PMDA company code | 230124 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: